Adma Biologics | ADMA - 销售成本

金融业

USD

USD 624.24M

现金及等价物

USD 87.63M

USD 50.4M

USD 466.51M

USD 69.54M

USD 83.12M

USD 62.75M

USD 73.59M

624

EPS每股收益

USD 0.2

股本和储备

USD 477.32M

USD 88.82M

债务利息支出

USD 1.63M

USD 376K

USD 69.33M

USD 3.46B

USD 49.38M

USD 76.41M

USD 62.75M

普通股股本

USD 237.88M

29.73

USD 61.59M

USD 139.16M

销售和管理费用

USD 20.19M

USD 206.47M

贸易债权人

USD 22.52M

应收帐款人

USD 158.43M

	销售成本	更改		日
Adma Biologics	USD 50.4M		8.24M	2025-12
Alnylam Pharmaceuticals	USD 267.72M		67.57M	2025-12
BioCryst Pharmaceuticals	USD 9.52M		7.34M	2025-12
Minerva Neurosciences	386K		31K	2024-06
Novavax	USD 22.1M		608K	2025-12
Omeros	USD 33.16M		18.52M	2024-06
Takeda	JPY 401.15B		184.07B	2025-12